HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arun Prashanth Selected Research

Angiofibroma

8/2021Physiological PSMA Uptake in the Tubarial Salivary Glands and Its Implications in the PARIS Protocol-A First Study of Its Kind!
7/2021Fusion 68Ga-DOTANOC PET/MRI in Primary Juvenile Nasal Angiofibroma.
5/2021Clinical utility of Ga68 DOTANOC PET/CT imaging in juvenile nasal angiofibroma and the PARIS protocol: a preliminary report.
5/2021Validation of Postoperative Angiofibroma Radionuclide Imaging Study (PARIS) Protocol Using PSMA PET/CT-A Proof of Concept Study.
1/202168 Ga DOTANOC PET/CT Scan in Primary Juvenile Nasopharyngeal Angiofibroma - A Pilot Study.
10/2020Clinical Utility of 68Ga-DOTANOC Positron Emission Tomography-Computed Tomography Scan on Postoperative Assessment of Juvenile Nasal Angiofibroma.
4/2020Comparison of 68Ga-PSMA PET/CT and Contrast-Enhanced MRI on Residual Disease Assessment of Juvenile Nasal Angiofibroma.
4/2020Juvenile Nasal Angiofibroma on 68Ga-DOTANOC PET/CT: Exploring Theranostic Avenues.
3/2020Prostate-Specific Membrane Antigen Expression in Primary Juvenile Nasal Angiofibroma-A Pilot Study.
2/2020Clinical Utility of 68Ga-Prostate-Specific Membrane Antigen PET/CT Scan on Postoperative Assessment of Juvenile Nasal Angiofibroma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Arun Prashanth Research Topics

Disease

12Angiofibroma
08/2021 - 02/2019
6Neoplasms (Cancer)
08/2021 - 02/2020
3Neuroendocrine Tumors (Neuroendocrine Tumor)
07/2021 - 04/2020
2Cicatrix (Scar)
07/2021 - 04/2020
2Neoplasm Metastasis (Metastasis)
07/2021 - 06/2019
2Prostatic Neoplasms (Prostate Cancer)
03/2020 - 02/2019
1Chylothorax
09/2021
1Cysts
09/2021
1Lymphocele
09/2021
1Breast Neoplasms (Breast Cancer)
07/2020
1Pancreatitis
06/2020
1Fat Necrosis
06/2020
1Neurofibrosarcoma (MPNST)
06/2019

Drug/Important Bio-Agent (IBA)

6AntigensIBA
08/2021 - 02/2019
368Ga-DOTANOCIBA
07/2021 - 04/2020
3gallium 68 PSMA-11IBA
04/2020 - 02/2019
2Radioisotopes (Radionuclides)IBA
08/2021 - 05/2021
2LigandsIBA
08/2021 - 04/2020
21,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
05/2021 - 01/2021
1Colloids (Colloid)IBA
09/2021
1Sodium Pertechnetate Tc 99m (Pertechnetate)FDA Link
09/2021
1methylene diphosphonateIBA
07/2021
13-Iodobenzylguanidine (Iobenguane)IBA
07/2021
1Octreotide (Sandostatin)FDA LinkGeneric
05/2021
1Somatostatin Receptors (Somatostatin Receptor)IBA
01/2021
1Estrogen ReceptorsIBA
07/2020
1Estrogens (Estrogen)FDA Link
07/2020
1Technetium Tc 99m MedronateIBA
06/2020
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
04/2020
1Cell Surface ReceptorsIBA
04/2020
1RadiopharmaceuticalsIBA
04/2020
1Tyrosine Kinase InhibitorsIBA
06/2019
1Sunitinib (Sutent)FDA Link
06/2019
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
06/2019
1liposomal doxorubicin (Doxil)FDA Link
06/2019

Therapy/Procedure

3Precision Medicine
07/2021 - 02/2019
2Radiotherapy
08/2021 - 07/2021
2Therapeutics
07/2021 - 04/2020